Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

BUY
N/A
4,600 Added 45.54%
14,700 $42,000
Q2 2024

Aug 14, 2024

SELL
N/A
-2,500 Reduced 19.84%
10,100 $29,000
Q1 2024

May 15, 2024

BUY
N/A
4,600 Added 57.5%
12,600 $36,000
Q4 2023

Feb 14, 2024

BUY
$1.08 - $2.92 $8,640 - $23,360
8,000 New
8,000 $23,000

Others Institutions Holding JUPW

About Jupiter Wellness, Inc.


  • Ticker JUPW
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 22,095,000
  • Market Cap $64.5M
  • Description
  • Jupiter Wellness, Inc. develops cannabidiol (CBD) based medical therapeutics and wellness products. The company's clinical pipeline includes CaniDermRX (JW-100), a novel topical formulation containing CBD and aspartame for the treatment of eczema, dermatitis, and actinic keratosis; JW-101, a prescription product for the treatment of burns; and J...
More about JUPW
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.